Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathologic findings of the placenta and clinical implications - recommendations for placental examination.

Swiss medical weekly·2024
Same author

Bladder Neoplasia in Pediatric Patients-A Single-Center Experience Including a Case Series.

Children (Basel, Switzerland)·2023
Same author

Extremely severe hypochloremic metabolic alkalosis after ileorectal anastomosis in a patient with chronic intestinal pseudo-obstruction.

Gastroenterology report·2023
Same author

A Case Study of Zoonotic <i>Chlamydia abortus</i> Infection: Diagnostic Challenges From Clinical and Microbiological Perspectives.

Open forum infectious diseases·2022
Same author

Post-mortem magnetic resonance imaging with computed tomography-guided biopsy for foetuses and infants: a prospective, multicentre, cross-sectional study.

BMC pediatrics·2022
Same author

Associations of Mucosal Nerve Fiber Innervation Density with Hirschsprung-Associated Enterocolitis: A Retrospective Three-Center Cohort Study.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie·2022

Related Experiment Video

Updated: Dec 31, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.1K

KIT, PDGFRalpha and EGFR analysis in nephroblastoma.

Sylvia C Wetli1, Ivo Leuschner, Dieter Harms

  • 1Institute for Pathology, Basel University Hospital, Schoenbeinstrasse 40, CH-4031 Basel, Switzerland.

Virchows Archiv : an International Journal of Pathology
|May 15, 2008
PubMed
Summary

This study found no mutations in KIT, PDGFRalpha, or epidermal growth factor receptor (EGFR) in nephroblastoma. While KIT and EGFR expression showed a trend with poor outcomes in high-risk tumors, tyrosine kinase inhibitors may not be effective without these specific mutations.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

34.0K

Related Experiment Videos

Last Updated: Dec 31, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.7K
The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

34.0K

Area of Science:

  • Pediatric Oncology
  • Molecular Pathology
  • Cancer Therapeutics

Background:

  • Nephroblastoma prognosis has improved, yet a high-risk subgroup requires novel therapeutic strategies.
  • Tyrosine kinase inhibitors targeting KIT, PDGFRalpha, and EGFR are effective in other cancers.
  • Investigating these targets in nephroblastoma could reveal new treatment avenues.

Purpose of the Study:

  • To analyze KIT, PDGFRalpha, and EGFR expression and mutations in nephroblastoma.
  • To determine if tyrosine kinase inhibition is a viable therapeutic strategy for nephroblastoma.
  • To correlate expression/mutation status with patient prognosis.

Main Methods:

  • Immunohistochemistry was used to analyze KIT and EGFR expression in 209 nephroblastomas.
  • Mutation analysis of KIT, PDGFRalpha, and EGFR genes was performed on 63 and 209 samples.
  • Correlation of molecular findings with clinical data and patient outcomes was assessed.

Main Results:

  • No mutations were detected in KIT, PDGFRalpha, or EGFR genes.
  • KIT and EGFR expression was observed in 10.5% and 14.8% of tumors, respectively.
  • KIT expression was more frequent in high-risk tumors (22.3%) compared to low-/intermediate-risk tumors (14.4%).
  • A trend suggested an association between KIT/EGFR expression and poor outcomes in high-risk nephroblastomas, but it was not statistically significant.

Conclusions:

  • KIT, PDGFRalpha, and EGFR mutations do not appear to play a significant role in nephroblastoma pathogenesis.
  • The absence of targetable mutations suggests that tyrosine kinase inhibitors may not be effective therapies for nephroblastoma.
  • Further research is needed to explore alternative therapeutic targets for high-risk nephroblastoma subgroups.